ArticleFrontiers in nutrition2026
Essential minerals and risk of pancreatic diseases: a large-scale prospective cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Pancreatic disorders are characterised by high mortality rates and limited therapeutic options and pose a global health challenge. As a dual-function organ with endocrine and exocrine roles, the pancreas exhibits a heightened sensitivity to the disruption of mineral homeostasis. However, the pathophysiological associations between mineral imbalances and pancreatic diseases remain controversial, and large-scale population studies validating these relationships are lacking. Methods: This prospective cohort study used data from the UK Biobank and enrolled 191,875 participants with a median follow-up of 13 years. A phenome-wide association study (PheWAS) was used to systematically evaluate the associations between mineral levels and multisystem disorders. Multivariate Cox proportional hazards regression models quantified risk associations, whereas restricted cubic spline analyses elucidated dose-response relationships. Results: PheWAS identified multiple significant associations within the digestive system, including cholelithiasis, gastritis/duodenitis, and pancreatic diseases. Elevated serum iodine and selenium levels demonstrated significant carcinogenic effects on pancreatic cancer. In contrast, copper, magnesium, and manganese exhibited protective effects against acute pancreatitis, with manganese displaying a U-shaped dose-response relationship. Subgroup analyses revealed increased iodine and selenium carcinogenicity in females, older individuals, and smokers, whereas metal-related protection was more pronounced in males and normal-weight individuals. Conclusion: Mineral homeostasis exerts systemic effects on digestive pathophysiology. Elevated iodine and selenium levels are modifiable risk factors for pancreatic carcinogenesis, particularly in females and older populations. The inverse association of copper, magnesium, and manganese with acute pancreatitis suggests that they are potential therapeutic targets. The attenuated association in chronic pancreatitis implies an etiological predominance of non-mineral mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.